SPP1 promotes cisplatin resistance in cervical cancer by regulating KRAS expression

Changchun Long, Shiqi Wang, Yiyong Wang · 2026

Read SPP1 promotes cisplatin resistance in cervical cancer by regulating KRAS expression by Changchun Long, Shiqi Wang, Yiyong Wang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0353621.txt.

Description

Long and colleagues, in a 2026 laboratory study, hunt for genes that help cervical cancer resist cisplatin, a widely used chemotherapy drug. Drug resistance is a major reason treatment fails. Their search through large cancer data sets singled out a gene called SPP1, which was turned up in tumor tissue.

Tests in cancer cells showed SPP1 levels were higher still in cells that had learned to resist cisplatin. Turning SPP1 down slowed cell growth, raised cell death, and made the drug work better. Turning it up did the opposite. The gene's effects ran in part through a second gene, KRAS: adjusting KRAS partly undid what SPP1 did to drug response. The authors propose that blocking the SPP1 to KRAS path could help restore the power of chemotherapy. The evidence so far comes from data sets and cells, not patients.

Catalog record

CREATORChangchun Long, Shiqi Wang, Yiyong Wang
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE39069
LICENSECC_BY
RIGHTSCC BY
SOURCEPLOS

Source: https://doi.org/10.1371/journal.pone.0353621

Browse the full library · About the Tower of Babel